ERIN DAYS: Open Payments
NPI 1972275287 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 56 payments from 10 companies in 2025. Trend: 2023 $943 · 2024 $258 · 2025 $1,028
Food & beverage: $1,028
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $605 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
| Alkermes, Inc. | 3 | $75 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Boston Scientific Corporation | 1 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, Auvelity, CAPLYTA, AUSTEDO XR, LYBALVI, EMBOLD Fibered, UZEDY, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
